WOOJUNG BIO, Inc. (KOSDAQ:215380)
1,850.00
-160.00 (-7.96%)
Last updated: Jun 26, 2025
WOOJUNG BIO Revenue
WOOJUNG BIO had revenue of 8.31B KRW in the quarter ending March 31, 2025, a decrease of -18.16%. This brings the company's revenue in the last twelve months to 41.36B, up 1.69% year-over-year. In the year 2024, WOOJUNG BIO had annual revenue of 43.20B with 11.87% growth.
Revenue (ttm)
41.36B
Revenue Growth
+1.69%
P/S Ratio
0.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
32.90B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 43.20B | 4.58B | 11.87% |
Dec 31, 2023 | 38.62B | -8.30B | -17.70% |
Dec 31, 2022 | 46.92B | 15.68B | 50.20% |
Dec 31, 2021 | 31.24B | -6.11B | -16.35% |
Dec 31, 2020 | 37.34B | 5.05B | 15.65% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
Doosan Enerbility | 15.88T |
Hanwha Aerospace | 15.28T |
KB Financial Group | 14.93T |